| Followers | 66 |
| Posts | 477 |
| Boards Moderated | 0 |
| Alias Born | 02/26/2019 |
Friday, August 09, 2019 8:13:54 PM
Kcsven
This is going to come across the wrong way, but I hope everyone takes the time to read and understand my message. First rule in this game is don’t ever get emotional about stocks. - credit Gordon Gecko, Wall St
We few, we band of brothers, who understand V, the efficacy of epa know we’re sitting on a winner but it’s like a tragic love affair. Too afraid to sell now and buy back later.
I’m not spouting any investing advice for anyone. That’s not my profession but just pointing out that everyone should take a deep breath here. Put aside the FUD and stay level headed.
Last couple weeks there were many who wanted to run JT out after the secondary. I was among the few who supported him then and even more so now
RAF said today he knows one person removed from JT, that he is a straight shooter. Honest Abe by nature. I can attest the same also one person removed. I remain confident and see this road ahead may bumpy. (But an aside- what do we all really want to know? ). (****is this still a winner? Will pps reflect it!******?)
Yes, I’m looking to buy more and just trying to time the dips
This is going to come across the wrong way, but I hope everyone takes the time to read and understand my message. First rule in this game is don’t ever get emotional about stocks. - credit Gordon Gecko, Wall St
We few, we band of brothers, who understand V, the efficacy of epa know we’re sitting on a winner but it’s like a tragic love affair. Too afraid to sell now and buy back later.
I’m not spouting any investing advice for anyone. That’s not my profession but just pointing out that everyone should take a deep breath here. Put aside the FUD and stay level headed.
Last couple weeks there were many who wanted to run JT out after the secondary. I was among the few who supported him then and even more so now
RAF said today he knows one person removed from JT, that he is a straight shooter. Honest Abe by nature. I can attest the same also one person removed. I remain confident and see this road ahead may bumpy. (But an aside- what do we all really want to know? ). (****is this still a winner? Will pps reflect it!******?)
Yes, I’m looking to buy more and just trying to time the dips
Recent AMRN News
- Amarin Highlights New REDUCE-IT Analysis Showing Risk-Weighted ApoB May Improve Cardiovascular Risk Detection (AMRN) • IH Market News • 05/27/2026 03:24:38 PM
- New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia • GlobeNewswire Inc. • 05/27/2026 12:00:00 PM
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy • IH Market News • 04/29/2026 02:19:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 11:06:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:05:15 AM
- Amarin Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
